<DOC>
	<DOCNO>NCT02100800</DOCNO>
	<brief_summary>Emphysema major pathological feature Chronic Obstructive Pulmonary Disease ( COPD ) . Non-invasive assessment emphysema crucial issue phenotype follow-up COPD patient . Currently , CT method reference evaluate quantify emphysema remain radiation-based technique . Magnetic Resonance Imagery ( MRI ) ultrashort echo time ( UTE ) pulse sequence promise non-ionizing alternative lung imaging . Our objective evaluate emphysema COPD patient use CT MR-UTE , test agreement technique .</brief_summary>
	<brief_title>Assessment Emphysema Using 1.5T MRI With UTE Pulse Sequences</brief_title>
	<detailed_description>COPD major public health problem pathologically characterize lung emphysema bronchial remodeling . Emphysema define irreversible destruction alveolar wall subsequent enlargement air space . New targeted therapy emphysema currently develop , thereby stress need non-invasive tool aim quantify emphysema . Multi-slice compute tomography ( CT ) method reference quantify emphysema involves ionize radiation , thus limit possibility long-term follow-up . MRI non-ionizing 3D imaging technique ; however , lung MRI technically challenge result currently use routine practice . Indeed , low proton density susceptibility effect lead low signal intensity derive lung parenchyma . Recently , pulse sequence ultrashort echo time ( UTE ) implement use half radio-frequency excitation radial projection reconstruction . These UTE sequence make theoretically possible retrieve signal lung parenchyma . We aim use 3D T1-weighted UTE pulse sequence 1.5T magnet ( Avanto dot , Siemens ) COPD patient order distinguish normal lung emphysematous area . Thirty COPD patient 10 volunteer expect take part study . All benefit Pulmonary Functional Testing ( PFT ) , CT MRI . Our strategy consist quantify pulmonary emphysema use MRI CT subject , test correlation MR CT measurement assess reproducibility emphysema quantification use MRI . Our objective demonstrate MR-UTE pulse sequence 1.5T accurate reproducible evaluate quantify pulmonary emphysema .</detailed_description>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<criteria>Male female age 40 year . COPD group : patient diagnosis COPD distance ( minimum 4 week ) acute exacerbation ; stag 14 accord 2010 GOLD guideline . PFTs chest CTscan available within maximum 30 day inclusion . Control group : subject without chronic symptom cough expectoration ( StGeorges symptom score &lt; 5 % ) , normal chest CTscans perform pretherapeutic workup extrapulmonary cancer within maximum 30 day inclusion . These subject age sexmatched COPD patient . With write informed consent health insurance . Subjects without social security health insurance . History asthma , lung fibrosis , pulmonary hypertension cystic fibrosis . Pregnancy . Any respiratory treatment control subject . MRI contraindication : Magnetically activate implanted device ( cardiac pacemaker , insulin pump , neurostimulators , cochlear implant ) , metal inside eye brain ( aneurysm clip , ocular foreign body ) , cardiac valvular prosthesis ( StarrEdwards pre6000 ) , subject claustrophobia .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>COPD</keyword>
	<keyword>Emphysema</keyword>
	<keyword>MRI</keyword>
	<keyword>UTE</keyword>
	<keyword>Quantification</keyword>
	<keyword>CT</keyword>
</DOC>